Health In Tech, Inc. — Form 8-K
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 52/100
What the filing says
Health In Tech reported Q2 2026 GAAP revenue of $8.1M (down 13.5% from $9.3M YoY), attributed to timing shifts from onboarding a new carrier partner. The company introduced contracted revenue ($32.3M for H1 2026) and pipeline revenue ($66.3M as of July 31) as primary performance metrics, reaffirming full-year 2026 guidance of $45–$50M. Distribution partners grew 19.9% to 933; adjusted EBITDA was negative $1.3M for the quarter.
Why this rating
Revenue decline signals near-term pressure for $12.7M market-cap company; however, contracted/pipeline metrics and 20% partner growth suggest underlying momentum. Metric reframing is a moderate strategic shift but doesn't yet alter fundamentals.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.